168846-19-3

Upstream product

• 168845-88-3 4-azido-3-O-<2',6'-bis(2,4-dinitrophenylamino)-2',3',4',6'-tetradeoxy-α-D-erythro-hexopyranosyl>-1-N,2-O-carbonyl-1,4,5-trideoxy-6-O-methyl-1-(methylamino)-L-chiro-inositol 
• 87902-31-6 DL-(1α,2β,3β,4α,6β)-6-azido-2-O,3-N-carbonyl-4-O-methyl-3-(methylamino)-1,2,4-cyclohexanetriol 

Downstream Products

• 168845-98-5 4-azido-3-O-<2',6'-bis(benzyloxycarbonylamino)-2',3',4',6'-tetradeoxy-α-D-erythro-hexopyranosyl>-1,4,5-trideoxy-6-O-methyl-1-(methylamino)-L-chiro-inositol 
• 168846-00-2 4-azido-3-O-<2',6'-bis(benzyloxycarbonylamino)-2',3',4',6'-tetradeoxy-α-D-erythro-hexopyranosyl>-1,4,5-trideoxy-6-O-methyl-1-(benzyloxycarbonylglycyl)-methylamino-L-chiro-inositol 

Relevant academic research and scientific papers

Sannamycin-Type Aminoglycoside Antibiotics of Natural and Non-Natural (Mirror-Image) Configuration - Total Syntheses and Biological Activity

Sets of variously protected purpurosamine/2-epi-purpurosamine-type glycosyl donors (O-acetates) and sannamine-type glycosyl acceptors were coupled as racemates and pure enantiomers, according to a modified Koenigs-Knorr procedure with TMSOTf as promotor.T